Access to medicines by patients of the primary health care in the Brazilian Unified Health System

Abstract

OBJECTIVE To evaluate the access to medicines in primary health care of the Brazilian Unified Health System (SUS), from the patients’ perspective.METHODS This is a cross-sectional study that used data from the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos – Services, 2015 (PNAUM – National Survey on Access, Use and Promotion of Rational Use of Medicines), conducted by interviews with 8,591 patients in cities of the five regions of Brazil. Evaluation of access to medicines used concepts proposed by Penshansky and Thomas (1981), according to the dimensions: availability, accessibility, accommodation, acceptability, and affordability. Each dimension was evaluated by its own indicators.RESULTS For the “availability” dimension, 59.8% of patients reported having full access to medicines, without significant difference between regions. For “accessibility,” 60% of patients declared that the basic health unit (UBS) was not far from their house, 83% said it was very easy/easy to get to the UBS, and most patients reported that they go walking (64.5%). For “accommodation,” UBS was evaluated as very good/good for the items “comfort” (74.2%) and “cleanliness” (90.9%), and 70.8% of patients reported that they do not wait to receive their medicines, although the average waiting time was 32.9 minutes. For “acceptability,” 93.1% of patients reported to be served with respect and courtesy by the staff of the dispensing units and 90.5% declared that the units’ service was very good/good. For “affordability,” 13% of patients reported not being able to buy something important to cover expenses with health problems, and 41.8% of participants pointed out the expense with medicines.CONCLUSIONS Results show 70%–90% compliance, which is compatible with developed countries. However, access to medicines remains a challenge, because it is still heavily compromised by the low availability of essential medicines in public health units, showing that it does not occur universally, equally, and decisively to the population.

Consumption and Lack of Access to Medicines and Associated Factors in the Brazilian Amazon: A Cross-Sectional Study, 2019

“…Our study found an increased lack of access to treatments when compared to a population-based study conducted in Porto Alegre, Southern Brazil with 2,988 individuals in 2003, which found that 5% of the participants who used medicines in the 15 days prior to the interview could not obtain appropriate treatment ( Bertoldi et al., 2009 ). Previous data from population-based studies reinforce the differences in the access to treatments between Brazilian regions, particularly in the North and Northeast regions, the least developed of the country ( Paniz et al., 2008 ; Goes et al., 2016 ; Alvares et al., 2017 ).…”

Saberes E Práticas Das Mães Sobre as Práticas Integrativas E Complementares Durante O Aleitamento Materno

“…Na forma de admissão do usuário com hanseníase no CSEM, destacou-se o modo de entrada do tipo caso novo, perfazendo-se, desta forma, a Atenção Primária em Saúde como a primeira porta de entrada aos serviços do Sistema Único de Saúde (ALVARES, 2017).…”

Challenges facing drug utilization research in the Latin American region

“…130 In Brazil, the list of essential drugs has been reported to include discrepancies between the WHO recommendations and the drugs included in the Brazilian National Relation of Essential Medicines, [131][132][133][134][135][136] as well as, that there is low availability of essential medicines in public health units. 137 Because the list is not even in use in most LatAm countries, investigators are encouraged to verify if the essential drug list is up to date and to validate the list prior to implementing any DUR studies.…”